{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:34:37Z","timestamp":1795048477420,"version":"4.10.2"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cytogfr.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T01:19:26Z","timestamp":1622164766000},"page":"120-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1633-1552","authenticated-orcid":false,"given":"Kiran","family":"Shabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3504-7373","authenticated-orcid":false,"given":"James E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7961-7753","authenticated-orcid":false,"given":"Islam","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seley","family":"Gharanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-8164","authenticated-orcid":false,"given":"Martin O.","family":"Weickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-9195","authenticated-orcid":false,"given":"Thomas M.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6997-3439","authenticated-orcid":false,"given":"Ioannis","family":"Kyrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpal S.","family":"Randeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2021.05.002_bib0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.metabol.2018.09.005","article-title":"The epidemiology of obesity","volume":"92","author":"Chooi","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","article-title":"The obesity transition: stages of the global epidemic","volume":"7","author":"Jaacks","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0020","series-title":"Endotext","article-title":"Clinical problems caused by obesity","author":"Kyrou","year":"2018"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0025","series-title":"Endocrinol. Hear. Heal. Dis. Integr. Cell. Mol. Endocrinol. Hear.","first-page":"167","article-title":"Adipokines","author":"Kyrou","year":"2016"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2016.00030","article-title":"Adipose tissue remodeling: its role in energy metabolism and metabolic disorders","volume":"7","author":"Choe","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41574-019-0230-6","article-title":"The endocrine function of adipose tissues in health and cardiometabolic disease","volume":"15","author":"Scheja","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2020.04.009","article-title":"Adipokines as novel biomarkers of cardio-metabolic disorders","volume":"507","author":"Su","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2020.568800","article-title":"Newly discovered adipokines: pathophysiological link between obesity and cardiometabolic disorders","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1474651412464794","article-title":"Dysregulated adipokines in the pathogenesis of type 2 diabetes and vascular disease","volume":"12","author":"Brown","year":"2012","journal-title":"Br. J. Diabetes Vasc. Dis."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0055","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2016.06.072","article-title":"The adipokine-cardiovascular-Lifestyle network: translation to clinical practice","volume":"68","author":"Mechanick","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a Fasting-Induced Glucogenic Protein Hormone","volume":"165","author":"Romere","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2016.06.009","article-title":"Expression of FBN1 during adipogenesis: relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions","volume":"119","author":"Davis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0070","doi-asserted-by":"crossref","first-page":"109737","DOI":"10.1016\/j.enzmictec.2020.109737","article-title":"Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK","volume":"144","author":"Zhang","year":"2021","journal-title":"Enzyme Microb. Technol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0075","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/ajmg.a.36157","article-title":"Severe congenital lipodystrophy and a progeroid appearance: mutation in the penultimate exon of FBN1 causing a recognizable phenotype","volume":"161","author":"Takenouchi","year":"2013","journal-title":"Am. J. Med. Genet. Part A."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0080","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","article-title":"Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2019 terminus of the FBN1-gene","volume":"152","author":"Graul-Neumann","year":"2010","journal-title":"Am. J. Med. Genet. Part A."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0085","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejmg.2014.02.012","article-title":"Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3\u2019 end of FBN1 gene","volume":"57","author":"Jacquinet","year":"2014","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0090","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ajmg.a.33906","article-title":"Further evidence for a marfanoid syndrome with neonatal progeroid features and severe generalized lipodystrophy due to frameshift mutations near the 3\u2019 end of the FBN1 gene","volume":"155","author":"Goldblatt","year":"2011","journal-title":"Am. J. Med. Genet. Part A."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25040775","article-title":"An MRM-based multiplexed quantification assay for human adipokines and apolipoproteins","volume":"25","author":"Krieg","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0100","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.4432","article-title":"Asprosin is a centrally acting orexigenic hormone","volume":"23","author":"Duerrschmid","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cmet.2019.05.022","article-title":"OLFR734 mediates glucose metabolism as a receptor of asprosin","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.cmet.2019.05.022","article-title":"OLFR734 mediates glucose metabolism as a receptor of asprosin","volume":"30","author":"Li","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrg1556","article-title":"The genetics of human obesity","volume":"6","author":"Bell","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-020-0152-4","article-title":"The Asprosin\u2013OLFR734 module regulates appetitive behaviors","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0125","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3389\/fphys.2019.01151","article-title":"Sense of smell as the central driver of pavlovian appetite behavior in mammals","volume":"10","author":"Fine","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0130","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-0528.2006.01004.x","article-title":"Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue","volume":"113","author":"Cancello","year":"2006","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.metabol.2013.12.002","article-title":"Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance","volume":"63","author":"Van Beek","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI88880","article-title":"Skeletal muscle inflammation and insulin resistance in obesity","volume":"127","author":"Wu","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0145","doi-asserted-by":"crossref","first-page":"20888","DOI":"10.1002\/jcp.28694","article-title":"Asprosin attenuates insulin signaling pathway through PKC\u03b4-activated ER stress and inflammation in skeletal muscle","volume":"234","author":"Jung","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bj20031493","article-title":"Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase C\u03b4","volume":"378","author":"Greene","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0155","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.2337\/db14-1891","article-title":"Role of PKC\u03b4 in insulin sensitivity and skeletal muscle metabolism","volume":"64","author":"Li","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0160","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1006\/cyto.1998.0496","article-title":"Protein kinase C-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-\u03b1, IL-1\u03b2, IL-6)","volume":"11","author":"Kontny","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0165","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3389\/fphar.2018.01554","article-title":"The distinct effects of palmitic and oleic acid on pancreatic beta cell function: the elucidation of associated mechanisms and effector molecules","volume":"9","author":"Nemecz","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","article-title":"Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation","volume":"486","author":"Lee","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0175","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41366-018-0248-1","article-title":"Serum asprosin levels and bariatric surgery outcomes in obese adults","volume":"43","author":"Wang","year":"2019","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2521096","article-title":"Saliva and blood asprosin hormone concentration associated with obesity","volume":"2019","author":"Ugur","year":"2019","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0185","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1080\/07420528.2020.1792482","article-title":"Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight\/obese versus normal weight adult men","volume":"37","author":"Ceylan","year":"2020","journal-title":"Chronobiol. Int."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/ped.14176","article-title":"Increased serum circulating asprosin levels in children with obesity","volume":"62","author":"Silistre","year":"2020","journal-title":"Pediatr. Int. (Roma)"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6622129","article-title":"High serum asprosin levels are associated with presence of metabolic syndrome","volume":"2021","author":"Hong","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000500523","article-title":"Decreased circulating levels of Asprosin in obese children","volume":"91","author":"Long","year":"2019","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0205","doi-asserted-by":"crossref","first-page":"155477","DOI":"10.1016\/j.cyto.2021.155477","article-title":"Asprosin serum levels and glucose homeostasis in children with obesity","volume":"142","author":"Corica","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0210","first-page":"3","article-title":"Increased plasma asprosin levels in patients with drug-naive anorexia nervosa","volume":"1","author":"Hu","year":"2020","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","article-title":"Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride","volume":"489","author":"Zhang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0220","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7375294","article-title":"Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases","volume":"2018","author":"Li","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.13148","article-title":"Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0230","doi-asserted-by":"crossref","DOI":"10.1186\/s13098-020-00564-w","article-title":"Serum concentration of asprosin in new-onset type 2 diabetes","volume":"12","author":"Naiemian","year":"2020","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0235","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9471583","article-title":"Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion","volume":"2018","author":"Wang","year":"2018","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0240","doi-asserted-by":"crossref","DOI":"10.5603\/EP.a2020.0017","article-title":"Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin","author":"Gozel","year":"2020","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0245","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/17512433.2017.1322507","article-title":"A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus","volume":"10","author":"Avogaro","year":"2017","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-021-00652-5","article-title":"Effect of sodium-glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus","volume":"13","author":"Jiang","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0255","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0260","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ncpendmet0894","article-title":"The pathogenesis of diabetic nephropathy","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0265","first-page":"4341","article-title":"Higher serum asprosin level is associated with urinary albumin excretion and renal function in type 2 diabetes, Diabetes","volume":"13","author":"Deng","year":"2020","journal-title":"Metab. Syndr. Obes. Targets Ther."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0270","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1210\/jc.2006-0980","article-title":"Modulation of adipokines and cytokines in gestational diabetes and Macrosomia","volume":"91","author":"At\u00e8gbo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0275","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S2213-8587(13)70176-1","article-title":"Adipokines in gestational diabetes","volume":"2","author":"Fasshauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0280","doi-asserted-by":"crossref","first-page":"170132","DOI":"10.1016\/j.peptides.2019.170132","article-title":"Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus","volume":"120","author":"Baykus","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2020.02.004","article-title":"Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: a nested case-control study","volume":"93","author":"Zhong","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0290","first-page":"54","article-title":"Plasma Asprosin Levels Changes in Pregnant and Non-Pregnant Rats with and without Gestational Diabetes","author":"Rezk","year":"2020","journal-title":"Int. J. Med. Res. Heal. Sci."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0295","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0300","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbalip.2009.10.007","article-title":"Fatty liver and lipotoxicity","volume":"1801","author":"Trauner","year":"2010","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0305","doi-asserted-by":"crossref","first-page":"155184","DOI":"10.1016\/j.cyto.2020.155184","article-title":"Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease","volume":"134","author":"Ke","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0310","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/JME-17-0096","article-title":"Adiponectin improves insulin sensitivity via activation of autophagic flux","volume":"59","author":"Ahlstrom","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0315","article-title":"Evaluation of serum and salivary subfatin and asprosin hormone levels in patients with nonalcoholic steatohepatisis","volume":"70","author":"Cosar","year":"2020","journal-title":"Endocr. Abstr."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0320","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(09)62023-7","article-title":"Dilated cardiomyopathy","volume":"375","author":"Jefferies","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-020-01680-1","article-title":"The role of Asprosin in patients with dilated cardiomyopathy","volume":"20","author":"Wen","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0330","doi-asserted-by":"crossref","first-page":"116554","DOI":"10.1016\/j.lfs.2019.116554","article-title":"Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1\/2-SOD2 pathway","volume":"231","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/569862","article-title":"Phenotype and metabolic disorders in polycystic ovary syndrome","volume":"2012","author":"Gluszak","year":"2012","journal-title":"ISRN Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0340","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0345","series-title":"Endocrinol. Diabetes Case Stud. Quest. Comment","first-page":"99","article-title":"Diagnosis and management of polycystic ovary syndrome (PCOS)","author":"Kyrou","year":"2015"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0350","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and Polycystic Ovary Syndrome","volume":"65","author":"Barber","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0355","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/obe.2007.0019","article-title":"Obesity and polycystic ovary syndrome","volume":"3","author":"Sam","year":"2007","journal-title":"Obes. Manag."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0360","first-page":"1","article-title":"Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome","author":"Alan","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0365","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/s41598-019-42061-9","article-title":"The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients","volume":"9","author":"Chang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0370","article-title":"Fasted plasma asprosin concentrations are associated with menstrual cycle phase, oral contraceptive use and training status in healthy women","author":"Leonard","year":"2020","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0375","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/spmg.21362","article-title":"Impact of obesity on male fertility, sperm function and molecular composition","volume":"2","author":"Palmer","year":"2012","journal-title":"Spermatogenesis"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0380","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41421-019-0122-x","article-title":"The Asprosin-OLFR734 hormonal signaling axis modulates male fertility","volume":"5","author":"Wei","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/726861","article-title":"Exercise induced adipokine changes and the metabolic syndrome","volume":"2014","author":"Golbidi","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12061899","article-title":"The role of exercise in the interplay between myokines, hepatokines, osteokines, adipokines, and modulation of inflammation for energy substrate redistribution and fat mass loss: a review","volume":"12","author":"Gonzalez-Gil","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0395","article-title":"Aerobic exercise training decreases hepatic asprosin in diabetic rats","volume":"666","author":"Ko","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0400","doi-asserted-by":"crossref","DOI":"10.2337\/db18-2441-PUB","article-title":"Regulation of hepatic glucose production by transforming growth factor Beta 1 via protein kinase a","volume":"67","author":"Pan","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0405","doi-asserted-by":"crossref","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","article-title":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK)","volume":"289","author":"Cao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0410","doi-asserted-by":"crossref","first-page":"100111","DOI":"10.1016\/j.obmed.2019.100111","article-title":"Effect of swimming training on levels of asprosin, lipid profile, glucose and insulin resistance in rats with metabolic syndrome","volume":"15","author":"Nakhaei","year":"2019","journal-title":"Obes. Med."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.01782","article-title":"Acute anaerobic exercise affects the secretion of asprosin, irisin, and other cytokines - A comparison between sexes","volume":"9","author":"Wiecek","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12576-013-0269-4","article-title":"Whole-body cryostimulation as an effective method of reducing low-grade inflammation in obese men","volume":"63","author":"Ziemann","year":"2013","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0425","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/803197","article-title":"Body composition, lipid profile, adipokine concentration, and antioxidant capacity changes during interventions to treat overweight with exercise programme and whole-body cryostimulation","volume":"2015","author":"Lubkowska","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cytogfr.2021.05.002_bib0430","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/jcm8091428","article-title":"Decreased blood asprosin in hyperglycemic menopausal women as a result of whole-body cryotherapy regardless of metabolic syndrome","volume":"8","author":"Wiecek","year":"2019","journal-title":"J. Clin. Med."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610121000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:58:05Z","timestamp":1761217085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610121000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":86,"alternative-id":["S1359610121000435"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.05.002","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}